Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

PBLS – Parabilis Medicines Inc

Parabilis Medicines, Inc.
PBLS
$29.65
Name : Parabilis Medicines, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $3,662,760,448.00
EPSttm : -9.51
finviz dynamic chart for PBLS
Parabilis Medicines, Inc.
$29.65
1.23%
$0.37
[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=PBLS#%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]
PBLS — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

14.26

Margin Of Safety %

Put/Call OI Ratio

0.56

EPS Next Q Diff

1.73

EPS Last/This Y

-0.77

EPS This/Next Y

0.39

Price

29.64

Target Price

41

Analyst Recom

1

Performance Q

-16.88

Upside

N/A

Beta

Ticker: PBLS




22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-10-13PBLS26.790.520.00572
2026-10-14PBLS25.90.520.67574
2026-10-15PBLS25.160.52999.99582
2026-10-16PBLS22.690.52999.99582
2026-10-19PBLS25.340.290.35409
2026-10-20PBLS27.120.270.00433
2026-10-21PBLS27.860.250.00468
2026-10-22PBLS26.930.250.00479
2026-10-23PBLS24.430.240.30484
2026-10-26PBLS25.010.24999.99495
2026-10-27PBLS26.60.24999.99495
2026-10-28PBLS28.280.24999.99495
2026-10-29PBLS28.740.211.00481
2026-10-30PBLS28.370.2153.33481
2026-11-02PBLS27.270.2114.55481
2026-11-03PBLS29.310.540.00621
2026-11-04PBLS30.380.540.67622
2026-11-05PBLS27.890.545.00613
2026-11-06PBLS28.560.52999.99605
2026-11-09PBLS30.340.560.00620
2026-11-10PBLS30.060.560.00620
2026-11-11PBLS29.640.560.00621
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-10-13PBLS26.80- - -2.58
2026-10-14PBLS25.90- - -2.58
2026-10-15PBLS25.19- - -2.58
2026-10-16PBLS22.74- - -2.58
2026-10-19PBLS25.34- - -2.58
2026-10-20PBLS25.34- - -2.58
2026-10-21PBLS27.06- - -2.58
2026-10-22PBLS26.90- - -2.58
2026-10-23PBLS24.47- - -2.58
2026-10-26PBLS25.00- - -2.58
2026-10-27PBLS26.55- - -2.58
2026-10-28PBLS28.22- - -2.58
2026-10-29PBLS28.70- - -2.58
2026-10-30PBLS28.33- - -2.58
2026-11-02PBLS27.31- - -2.58
2026-11-03PBLS29.28- - -2.58
2026-11-04PBLS30.39- - -2.58
2026-11-05PBLS27.89- - -2.58
2026-11-06PBLS28.52- - -2.58
2026-11-09PBLS30.38- - -2.58
2026-11-10PBLS30.03- - -2.58
2026-11-11PBLS29.64- - -2.58
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-10-13PBLS91.17120.5710.66
2026-10-14PBLS91.17120.5710.66
2026-10-15PBLS91.17120.5710.66
2026-10-16PBLS91.17120.5710.66
2026-10-19PBLS91.18120.6510.66
2026-10-20PBLS91.18120.6510.66
2026-10-21PBLS91.17120.6510.66
2026-10-22PBLS91.17120.6510.66
2026-10-23PBLS91.17120.6510.66
2026-10-26PBLS91.18117.3110.66
2026-10-27PBLS91.17117.3111.94
2026-10-28PBLS91.17117.3111.94
2026-10-29PBLS91.17117.3111.94
2026-10-30PBLS91.17117.3111.94
2026-11-02PBLS91.17120.6911.94
2026-11-03PBLS91.17120.6911.94
2026-11-05PBLS91.17120.6911.94
2026-11-06PBLS91.17120.6911.94
2026-11-09PBLS91.17113.6211.94
2026-11-10PBLS91.17113.6211.94
2026-11-11PBLS91.17113.6214.26
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=PBLS 589 360 ]

Last Quarter Act. EPS​

-2.13

Avg. EPS Est. Current Quarter

-0.38

Avg. EPS Est. Next Quarter

-0.4

Insider Transactions

91.17

Institutional Transactions

113.62

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

1

Fair Value

Quality Score

35

Growth Score

Sentiment Score

75

Actual DrawDown %

30.3

Max Drawdown 5-Year %

Target Price

41

P/E

Forward P/E

PEG

P/S

P/B

3.5

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

-2.58

EPS Next Y. (Est.)

-2.19

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.59

Return on Equity vs Sector %

-48.5

Return on Equity vs Industry %

-28.9

EPS 1 7Days Diff

-0.9

EPS 1 30Days Diff

-0.92

EBIT Estimation

[iframe https://widget.finnhub.io/widgets/recommendation?symbol=PBLS 589 450 ]
[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=PBLS 589 450 ]
◆ PBLS Healthcare
$29.65
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
12/20
Pullback
13/25
Volume
11/15
Valuation
8/20
TP/AR
6/10
Options
5/10
RSI
52.1
Range 1M
76.4%
Sup Dist
1.5%
🚀
Momentum Growth
Ride accelerating trends
N/A
26 /100
WEAK
Momentum
5/25
Growth
4/30
Estimates
6/20
Inst/Vol
5/15
Options
6/10
EPS Yr
0%
EPS NY
0%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +38.3% upside
Quality
3/30
Valuation
9/30
Growth
2/25
Stability
7/10
LT Trend
1/5
Upside
+38.3%
Quality
35
PBLS — P/E HistoricalBiotechnology
Parabilis Medicines, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 145
Parabilis Medicines, Inc. operates as a clinical-stage biopharmaceutical company focused on developing helical peptide therapeutics for disease treatment. The company develops stabilized helical peptide therapeutics through its Helicon discovery platform, targeting proteins that are traditionally considered undruggable. Its pipeline includes functional inhibitors of intracellular protein-protein interactions, targeted protein degraders, and targeted radiopharmaceuticals, with a lead clinical program, FOG-001, that acts as a TCF-blocking beta-catenin inhibitor for cancer treatment. The company integrates artificial intelligence and data science into drug discovery, trial design, and clinical strategy optimization. Parabilis Medicines serves clients in the healthcare and life sciences industries, including clinical research organizations and medical professionals involved in oncology and cancer treatment. The company was founded in 2015 and is based in Cambridge, Massachusetts.
PBLS

Latest News

—
Caricamento notizie per PBLS…
stock quote shares PBLS – Parabilis Medicines Inc Stock Price stock today
news today PBLS – Parabilis Medicines Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch PBLS – Parabilis Medicines Inc yahoo finance google finance
stock history PBLS – Parabilis Medicines Inc invest stock market
stock prices PBLS premarket after hours
ticker PBLS fair value insiders trading